Aortic Valve
The transition toward minimally invasive cardiac surgery is no longer solely about reducing incision size; it is about creating a standardized, versatile, and sustainable concept. The direct-view transaxillary approach represents a significant evolution that is...
The authors present a 75-year-old woman with dyspnea on exertion. She was diagnosed with an aortic valve stenosis and moderate-to-severe mitral valve regurgitation due to a localized A2 prolapse. This...
This cardiac session features leading surgeon Mario Castillo-Sang presenting on intraoperative pearls and pitfalls at the International Society for Minimally Invasive Cardiothoracic Surgery Annual Scientific Meeting 2026. CTSNet Senior Editor—Cardiac...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Aamir Amin, a cardiothoracic surgery resident at Manchester University NHS Foundation Trust, UK, about humanoid robots and artificial...
Three dimensional (3D) endoscopic aortic valve replacement combined with extended septal myectomy (the Morrow procedure) via right lateral minithoracotomy offers a safe and effective single-stage surgical solution for the rare...
This retrospective study evaluated the longitudinal outcomes of bioprosthetic (bAVR) versus mechanical surgical aortic valve replacement (mAVR) in Medicare beneficiaries aged 65 years old and older (n=69,423). After risk adjustment,...
This retrospective study evaluated the hemodynamics and durability of the Ozaki procedure in chronic dialysis patients compared to two groups: non-dialysis Ozaki patients and dialysis patients receiving bioprosthetic aortic valve...
This study conducted a systematic review and meta-analysis of randomized controlled trials comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in low- to intermediate- surgical risk...
In this article, the authors report six-year outcomes from the Evolut Low Risk trial, which randomized 1,414 low-risk patients with severe aortic stenosis to transcatheter aortic valve replacement (TAVR) (n=730)...
In this brief report, the authors present an ex vivo bench study evaluating the impact of post-dilation strategies on Evolut FX+ transcatheter heart valves (23, 26, 29, and 34 mm)....
In this article, the authors present the three-year results of the randomized LYTEN trial comparing balloon-expandable valves (BEV; SAPIEN 3/ULTRA) and self-expanding valves (SEV; Evolut R/PRO/PRO+) for valve-in-valve transcatheter aortic...
In this article, the authors present a bench-to-animal-to-human proof of concept for valve-in-mechanical (ViMech) transcatheter aortic valve implantation (TAVI) in patients with failed bileaflet mechanical aortic valves. Bench testing showed...
A systematic review and meta-analysis of six randomized controlled trials examined five-year outcomes comparing transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR) in 3,094 women with aortic...





